Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 42 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Genes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Hematopoiesis Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Stem Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2021

Therapeutic targeting of glutamine metabolism in MDS

Verma, A. K.

National Institutes of Health

4/1/163/31/21

Project: Research projectResearch Project

Myelodysplastic Syndromes
Glutamine
Glutaminase
Neoplasms
Methylation
Myelodysplastic Syndromes
MicroRNAs
Stem Cells
Hematopoiesis
Bone Marrow

The role of Dock4 in normal and aberrant erythropoiesis

Verma, A. K. & Wickrema, A.

National Institutes of Health

9/26/126/30/16

Project: Research projectResearch Project

Erythropoiesis
Myelodysplastic Syndromes
Erythroblasts
Anemia
Membranes

p38 MAPK--Therapeutic target in Myelodysplastic syndrome

Verma, A. K.

National Institutes of Health

9/30/057/31/10

Project: Research projectResearch Project

Myelodysplastic Syndromes
p38 Mitogen-Activated Protein Kinases
Bone Marrow
Hematopoiesis
Stromal Cells

Publications 1995 2017

  • 4469 Citations
  • 40 h-Index
  • 146 Article
  • 3 Review article
  • 1 Chapter

Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease

Janakiram, M., Verma, A., Wang, Y., Budhathoki, A., Suarez Londono, J., Murakhovskaya, I., Braunschweig, I. & Minniti, C. P. Jun 6 2017 In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer

Bhagat, T. D. , Zou, Y. , Huang, S. , Park, J. , Palmer, M. B. , Hu, C. , Li, W. , Shenoy, N. , Giricz, O. , Choudhary, G. , Yu, Y. , Ko, Y. A. , Izquierdo, M. C. , Park, A. S. D. , Vallumsetla, N. , Laurence, R. , Lopez, R. , Suzuki, M. , Pullman, J. , Kaner, J. & 8 others Gartrell, B., Hakimi, A. A., Greally, J. M., Patel, B., Benhadji, K., Pradhan, K., Verma, A. & Susztak, K. Jan 20 2017 In : Journal of Biological Chemistry. 292, 3, p. 837-846 10 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Epigenomics
Cape Verde
Contraception Behavior
Castration

Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma

Barta, S. K., Jain, R., Mazumder, A., Carter, J., Almanzar, L., Browne, R., Shahnaz, S., Elkind, R., Kaminetzky, D., Battini, R., Derman, O., Kornblum, N., Verma, A. & Braunschweig, I. 2017 In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Busulfan
Melphalan
Multiple Myeloma
Pharmacokinetics
Stem Cell Transplantation
1 Citations

Recurrent genetic defects on chromosome 5q in myeloid neoplasms

Hosono, N. , Makishima, H. , Mahfouz, R. , Przychodzen, B. , Yoshida, K. , Jerez, A. , LaFramboise, T. , Polprasert, C. , Clemente, M. J. , Shiraishi, Y. , Chiba, K. , Tanaka, H. , Miyano, S. , Sanada, M. , Cui, E. , Verma, A. K. , McDevitt, M. A. , List, A. F. , Saunthararajah, Y. , Sekeres, M. A. & 3 others Boultwood, J., Ogawa, S. & Maciejewski, J. P. 2017 In : Oncotarget. 8, 4, p. 6483-6495 13 p.

Research output: Contribution to journalArticle

Chromosomes
Mutation
Neoplasms
Chromosome Deletion
Genes
1 Citations

Stem and progenitor cell alterations in myelodysplastic syndromes

Shastri, A., Will, B., Steidl, U. & Verma, A. Mar 23 2017 In : Blood. 129, 12, p. 1586-1594 9 p.

Research output: Contribution to journalReview article

Myelodysplastic Syndromes
Stem Cells
Supravalvular Aortic Stenosis
Status Epilepticus
Hematopoietic Stem Cells